{
    "1": {
        "question": "What is the primary technique used in the FRoGS approach for functional representation of gene signatures?",
        "options": {
            "A": "One-hot encoding",
            "B": "Gene identity mapping",
            "C": "t-SNE",
            "D": "Word embedding",
            "E": "GO term mapping",
            "F": "I don't know"
        }
    },
    "2": {
        "question": "Which dataset is primarily used by the FRoGS methodology for compound-target predictions?",
        "options": {
            "A": "The Cancer Genome Atlas",
            "B": "Gene Expression Omnibus",
            "C": "ARCHS4",
            "D": "L1000",
            "E": "Human Protein Atlas",
            "F": "I don't know"
        }
    },
    "3": {
        "question": "What kind of network model is used to analyze and predict compound-gene interaction?",
        "options": {
            "A": "Siamese neural network",
            "B": "Convolutional neural network",
            "C": "Random forest",
            "D": "Support vector machine",
            "E": "Graph neural network",
            "F": "I don't know"
        }
    },
    "4": {
        "question": "What was highlighted as a limitation of early NLP techniques, which parallels the FRoGS context?",
        "options": {
            "A": "Over-reliance on feature selection",
            "B": "Inability to capture word semantics using one-hot encoding",
            "C": "Lack of syntax parsing",
            "D": "Improper sentiment analysis",
            "E": "Insufficient data scalability",
            "F": "I don't know"
        }
    },
    "5": {
        "question": "What was the key hypothesis proposed to improve gene signature comparisons?",
        "options": {
            "A": "Improving gene identity precision",
            "B": "Combining structural and identity-based data",
            "C": "Switching focus from gene identity to functional roles",
            "D": "Increasing dataset size for accurate predictions",
            "E": "Utilizing protein docking simulations",
            "F": "I don't know"
        }
    },
    "6": {
        "question": "What is the purpose of using a t-SNE projection in the context of FRoGS?",
        "options": {
            "A": "To visually confirm pathway enrichment",
            "B": "To separate transcriptional noise",
            "C": "To validate gene cluster embedding based on function",
            "D": "To enhance dimensionality reduction",
            "E": "To facilitate statistical testing",
            "F": "I don't know"
        }
    },
    "7": {
        "question": "Which type of analysis helps confirm the sensitivity of FRoGS in detecting shared functionality?",
        "options": {
            "A": "Multivariate logistic regression",
            "B": "Simulation of experimentally derived signature pairs",
            "C": "Comparing t-distributed coordinates",
            "D": "Gene expression hierarchy clustering",
            "E": "Signal comparison using Fisher\u2019s test",
            "F": "I don't know"
        }
    },
    "8": {
        "question": "What type of analysis did the study use to highlight difficulties faced by identity-based methods?",
        "options": {
            "A": "PCA analysis of gene overlap",
            "B": "Cluster bootstrapping",
            "C": "Pathway enrichment comparison",
            "D": "Fisher's exact test comparisons",
            "E": "Gene homology adjustment",
            "F": "I don't know"
        }
    },
    "9": {
        "question": "What does the term processing technique of the FRoGS methodology correspond to in NLP?",
        "options": {
            "A": "Syntax tree parsing",
            "B": "Semantic similarity computation",
            "C": "Tokenization",
            "D": "Named entity recognition",
            "E": "Word stemming",
            "F": "I don't know"
        }
    },
    "10": {
        "question": "Which hypergraph is used in forming the embeddings in FRoGS?",
        "options": {
            "A": "Gene annotation hypergraph",
            "B": "Gene-to-GO term hypergraph",
            "C": "Gene-expression hypergraph",
            "D": "Protein signaling hypergraph",
            "E": "Gene-interaction hypergraph",
            "F": "I don't know"
        }
    },
    "11": {
        "question": "Which of the following provides evidence of FRoGS's performance over existing systems?",
        "options": {
            "A": "Integration of drug chemical insights",
            "B": "Outperformance marked by pathway R-HSA-5576891",
            "C": "Lack of similarity to NLP techniques",
            "D": "Merging pathway data with cell division data",
            "E": "Independence from large datasets",
            "F": "I don't know"
        }
    },
    "12": {
        "question": "Which recall percentage was achieved by the FRoGS embedding-empowered prediction model?",
        "options": {
            "A": "24.9%",
            "B": "36.3%",
            "C": "15.9%",
            "D": "12.3%",
            "E": "20.7%",
            "F": "I don't know"
        }
    },
    "13": {
        "question": "How does the FRoGS model representation of gene signatures compare qualitatively with others?",
        "options": {
            "A": "Shows a decline due to overfitting",
            "B": "Remains qualitatively static",
            "C": "Outperforms, particularly for complex signatures",
            "D": "Underperforms during large-scale validation",
            "E": "Matches performance of random models",
            "F": "I don't know"
        }
    },
    "14": {
        "question": "What type of neural network is utilized for signature vector input comparisons?",
        "options": {
            "A": "Feedforward neural network",
            "B": "Siamese neural network",
            "C": "Convolutional neural network",
            "D": "Recurrent neural network",
            "E": "Graph neural network",
            "F": "I don't know"
        }
    },
    "15": {
        "question": "Which FIGURE or TABLE discusses the performance boost in compound target predictions using FRoGS?",
        "options": {
            "A": "Figure 3",
            "B": "Figure 2",
            "C": "Table 1",
            "D": "Supplementary Table 3",
            "E": "Table 4",
            "F": "I don't know"
        }
    },
    "16": {
        "question": "Where did FRoGS vectors demonstrate significant utility in predicting the mechanism of small molecules?",
        "options": {
            "A": "In genomics sequencing data",
            "B": "In protein docking simulations",
            "C": "In the L1000 target deconvolution",
            "D": "Within limited gene annotations",
            "E": "In single cell experiments",
            "F": "I don't know"
        }
    },
    "17": {
        "question": "What suggests that functional similarities align in the prediction model?",
        "options": {
            "A": "Similarity correlations on structural features",
            "B": "Functional roles of unknown annotations",
            "C": "High pQSAR model scores with established references",
            "D": "Pathway-specific empirical studies",
            "E": "Random sampling of genomic data",
            "F": "I don't know"
        }
    },
    "18": {
        "question": "How many categories of validation exist for ModelL predictions?",
        "options": {
            "A": "Three categories",
            "B": "Four categories",
            "C": "Five categories",
            "D": "Six categories",
            "E": "Two categories",
            "F": "I don't know"
        }
    },
    "19": {
        "question": "What does the term processing align along in MODEL L predictions?",
        "options": {
            "A": "GO statistical enrichment",
            "B": "Network analogy",
            "C": "Molecular results alignment",
            "D": "Recall rate testing",
            "E": "Logistic regression p-values",
            "F": "I don't know"
        }
    },
    "20": {
        "question": "Which represents the combined model improving Model pQSAR performance?",
        "options": {
            "A": "Statistical cytokine modeling",
            "B": "Gene-based correlation methods",
            "C": "Multi-modality LR predictor",
            "D": "Cluster-based predictions",
            "E": "Score-based hypothesis scavenging",
            "F": "I don't know"
        }
    },
    "21": {
        "question": "How many states define the encoding space of gene functional embeddings?",
        "options": {
            "A": "No defined states",
            "B": "Single state embeddings",
            "C": "Two types of embeddings",
            "D": "Four-dimensional embeddings",
            "E": "Multiple undefined states",
            "F": "I don't know"
        }
    },
    "22": {
        "question": "Which evidence supports the results quality of compound SAR probability with respect to a reference?",
        "options": {
            "A": "Advanced sequence alignment",
            "B": "Activity profile correlation",
            "C": "Normalized Z-score significance",
            "D": "RCMOS lab results",
            "E": "Expectation maximization checks",
            "F": "I don't know"
        }
    },
    "23": {
        "question": "Which contribution factor does NOT enhance the FRoGS results?",
        "options": {
            "A": "Transcriptional response overlap",
            "B": "Structural data assimilation",
            "C": "Receptor-ligand simulated bases",
            "D": "Pathway networking completeness",
            "E": "GO CPU computation efforts",
            "F": "I don't know"
        }
    },
    "24": {
        "question": "How are the profiles derived in pQSAR compound models characterized?",
        "options": {
            "A": "Functional enzyme profiles",
            "B": "Quantitative structure-activity",
            "C": "Gene-expressed external cues",
            "D": "Self-regulating pathways",
            "E": "Random selection structures",
            "F": "I don't know"
        }
    },
    "25": {
        "question": "On which basis are the predictions classified as 'super-confident'?",
        "options": {
            "A": "Active-transcription maintenance",
            "B": "Empirical data classification",
            "C": "Either known or validated with pIC50",
            "D": "High natural ligand affinity",
            "E": "Meta-data algorithm results",
            "F": "I don't know"
        }
    },
    "26": {
        "question": "What percentage of Model L predictions are supported by 'structure sure' classification?",
        "options": {
            "A": "1.6%",
            "B": "0.7%",
            "C": "3.5%",
            "D": "4.5%",
            "E": "5.0%",
            "F": "I don't know"
        }
    },
    "27": {
        "question": "Which tool assesses phenotype differential gene selection handling in the FRoGS model?",
        "options": {
            "A": "Impact lens diffusion technique",
            "B": "Linear weighted aggregation",
            "C": "Consensus embedding approach",
            "D": "Transformer-backward model",
            "E": "Crossover residual method",
            "F": "I don't know"
        }
    },
    "28": {
        "question": "In what form is a gene\u2019s input vector representation appended?",
        "options": {
            "A": "Dually hyper-inflated nodes",
            "B": "Simple scaling approach",
            "C": "Concatenated joint vectors",
            "D": "Parallel density vectors",
            "E": "Genomic mapping array",
            "F": "I don't know"
        }
    },
    "29": {
        "question": "How many compounds targeting AhR were profiled for confirmation?",
        "options": {
            "A": "312",
            "B": "180",
            "C": "369",
            "D": "500",
            "E": "250",
            "F": "I don't know"
        }
    },
    "30": {
        "question": "What method of confirmation was used for the kinase activity assays?",
        "options": {
            "A": "Normal light assay",
            "B": "TR-FRET",
            "C": "CTGF assessment",
            "D": "ICU spectral method",
            "E": "Assay randomness",
            "F": "I don't know"
        }
    },
    "31": {
        "question": "What limits the deep learning model's target recall enhancement concerning FRoGS?",
        "options": {
            "A": "Transcriptional data inaccurateness",
            "B": "Gene pathway mapping errors",
            "C": "Inherent data bias",
            "D": "Resultant pathway downstream effect",
            "E": "Chemical synthesis barriers",
            "F": "I don't know"
        }
    },
    "32": {
        "question": "What characteristic of ModelL aids in boosting activity model performance?",
        "options": {
            "A": "Vector pathway dimensional enhancement",
            "B": "Combined feature scaling",
            "C": "Functional in-vivo testing",
            "D": "Gene-transcription interpolation",
            "E": "Notation mapping resistance",
            "F": "I don't know"
        }
    },
    "33": {
        "question": "Which significant application did FRoGS facilitate that was unattainable before?",
        "options": {
            "A": "Real-time 3D gene interaction monitoring",
            "B": "Pharmacokinetics realignment",
            "C": "Transcriptional signal enhancement",
            "D": "High-quality target predictions without reliance on chemical structures",
            "E": "Immediate response scalability",
            "F": "I don't know"
        }
    },
    "34": {
        "question": "What does the response heatmap figure highlight?",
        "options": {
            "A": "Compound-to-ligand mapping efficiency",
            "B": "IC50 equity distribution",
            "C": "Biased pathway intervention spots",
            "D": "Selective kinase target profiles",
            "E": "Signal alternation frequencies",
            "F": "I don't know"
        }
    },
    "35": {
        "question": "What is a crucial aspect facilitating FRoGS extension to versatile datasets?",
        "options": {
            "A": "Decentralized computing frameworks",
            "B": "Dynamic node behavioral analysis",
            "C": "Pre-trained gene functional embeddings",
            "D": "Randomized inverted array structures",
            "E": "Pathway vertex covariance",
            "F": "I don't know"
        }
    },
    "36": {
        "question": "What does the Method experimenting with RWR test?",
        "options": {
            "A": "Node-to-node gab and flow analysis",
            "B": "Hyperedge sampling with flexibility",
            "C": "Systematic random sample representations",
            "D": "Graph proximity representing likelihood",
            "E": "Directed cyclic buffer throughput",
            "F": "I don't know"
        }
    },
    "37": {
        "question": "How does the accuracy of FRoGS embeddings compare under varying conditions?",
        "options": {
            "A": "Consistency is reduced with weaker signals",
            "B": "Accuracy increases with smaller datasets",
            "C": "Performance drops against external bias",
            "D": "Robust across signal strength variations",
            "E": "Narrowly beats random assignments",
            "F": "I don't know"
        }
    },
    "38": {
        "question": "Why does ModelL excel in identifying novel targets specific to transcriptional data?",
        "options": {
            "A": "By eliminating non-pathway genes",
            "B": "Generic pathway consistency data",
            "C": "Signal edge dilation",
            "D": "Because it bypasses structural constraints",
            "E": "Heuristic alignment configurations",
            "F": "I don't know"
        }
    },
    "39": {
        "question": "What represents a critical role for tryptamine's associative evaluation?",
        "options": {
            "A": "Standard value correction matrix",
            "B": "Algorithmic process equalization",
            "C": "CMap score contrast analysis",
            "D": "FRoGS structural correlation",
            "E": "Selective inhibition checkpoint",
            "F": "I don't know"
        }
    },
    "40": {
        "question": "What advantage does the FRoGS model representation provide over a one-hot encoding?",
        "options": {
            "A": "Improves predictive model aggregation",
            "B": "Facilitates faster dataset redundancy",
            "C": "Enhanced biological encoding depth",
            "D": "Hyperplane orthogonal representation",
            "E": "Isomorphic genetic insight",
            "F": "I don't know"
        }
    },
    "41": {
        "question": "Which principle is leveraged in FRoGS to formulate greater data efficiency?",
        "options": {
            "A": "Segmentation by weighted attributes",
            "B": "Guilt-by-association principle",
            "C": "Empirical regularization",
            "D": "Dimensional feature scaling",
            "E": "Philosophical stochasticity",
            "F": "I don't know"
        }
    },
    "42": {
        "question": "What innovation in the FRoGS method increases its performance over Fisher's exact test?",
        "options": {
            "A": "Inclusion of implicit vector tracing",
            "B": "Functional roles instead of identity",
            "C": "Expanded simplified contexts",
            "D": "Generic real-time optimization",
            "E": "Improved retention frequency join",
            "F": "I don't know"
        }
    },
    "43": {
        "question": "How is the performance evaluation mediated for predictive strength across annotations?",
        "options": {
            "A": "Standard recall process",
            "B": "Rooted balanced weight protocol",
            "C": "Logistic regression with rank consensus",
            "D": "Eigenvalue determination",
            "E": "Alpha-equilibrium assignment",
            "F": "I don't know"
        }
    },
    "44": {
        "question": "How do FRoGS embeddings utilize the ARCHS4 database?",
        "options": {
            "A": "As a DNA sequence pivot",
            "B": "To generate empirical expression profiles",
            "C": "For nucleotide alignment checks",
            "D": "For enhanced microarray output",
            "E": "To embed gene disorder correlations",
            "F": "I don't know"
        }
    },
    "45": {
        "question": "Which supplementary process complements FRoGS embeddings effectively?",
        "options": {
            "A": "Gene transcript expansion rush",
            "B": "Optimal neural divergence technique",
            "C": "Gene Ontology context mapping",
            "D": "High throughput SVR",
            "E": "Two-phase linear balance",
            "F": "I don't know"
        }
    },
    "46": {
        "question": "Which feature highlights the uniqueness of ModelL's signal processing?",
        "options": {
            "A": "Self-referential entropy check",
            "B": "Parallel array matching",
            "C": "Explicit boundary condition",
            "D": "Signal mapping independence",
            "E": "Gene structural pairing leadership",
            "F": "I don't know"
        }
    },
    "47": {
        "question": "Which advanced property did the application of ModelL expose?",
        "options": {
            "A": "Signal mimicry prevention",
            "B": "Pathway continuation drop",
            "C": "Cut-off blend examination",
            "D": "Transcriptional selective enhancement",
            "E": "Pioneer phase switch",
            "F": "I don't know"
        }
    },
    "48": {
        "question": "What near-future goal was mentioned concerning FRoGS's further improvement?",
        "options": {
            "A": "Integration with structure-based docking simulations",
            "B": "Transition to faster graphical models",
            "C": "Consistency-building through larger scale training",
            "D": "Regression impact stabilization",
            "E": "Upgrading genomic insight toolbox",
            "F": "I don't know"
        }
    },
    "49": {
        "question": "What obstacle is recognized in transcriptional profiling for ModelL improvements?",
        "options": {
            "A": "Regulatory pathway signal loss",
            "B": "Biometric verification lag",
            "C": "Downstream effect blurring",
            "D": "Parameter overestimation",
            "E": "Alignment synthesis error",
            "F": "I don't know"
        }
    },
    "50": {
        "question": "What key factor differentiates FRoGS's utility in predicting novel target relationships?",
        "options": {
            "A": "GO-term centered evaluation",
            "B": "Physics-centric approach",
            "C": "Chemical structure exclusion",
            "D": "Molecular signal resilience",
            "E": "Multiplex microarray usage",
            "F": "I don't know"
        }
    }
}